Dr. Dimah Al-Harbi
Dr. Dimah Alharbi earned a Doctor of Pharmacy (PharmD) with First Honors Degree from the College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia (2019). She completed a PGY2 Cardiology Pharmacy Residency Program at King Fahad Medical City in Riyadh (2023) and a two-year ASHP-accredited PGY1 Pharmacy Residency Program at King Abdulaziz Medical City and King Abdullah Specialist Children Hospital in Riyadh (2020-2022). She is a Cardiology clinical pharmacist at King Abdulaziz Medical City in Riyadh. She has published research on "Linezolid vs Vancomycin in Induced Thrombocytopenia" and is currently involved in several research projects in progress, including those assessing 30-day hospital readmission among orthopedic surgical patients, the evaluation of antifungals, and the effect of Ticagrelor vs Clopidogrel on Left Ventricular Remodeling. She has been recognized with the Dean's List Recognition and First Honor Degree, and has actively participated in community service and health awareness campaigns, including those for diabetes, medication safety, and infection prevention.
Publications